GRL0617 T11464
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 _M, Ki : 0.49 _M).
CAS nr:
1093070-16-6
Purity:
98%
Molecular Weight:
304,39
SMILES:
C[C@@H](NC(=O)c1cc(N)ccc1C)c1cccc2ccccc12
Formula:
C20H20N2O
Pathway:
Ubiquitination,Cell Cycle/Checkpoint,DNA Damage/DNA Repair,Microbiology/Virology
Target:
DUB,DUB,DUB,SARS-CoV
